Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.04
+0.03 (0.43%)
Aug 3, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Operating Income Operating Income Growth | -118.62 | -112.79 | -113.36 | -108.69 | -102.84 | -96.12 | -93.09 | -90.35 | -87.86 | -84.99 | -77.82 | -73.39 | -66.93 | -60.3 | -54.31 | -47.15 | -42.13 | -35.25 | -63.13 | -50.6 |
Net Income Net Income Growth | -112.39 | -106.19 | -106.47 | -101.38 | -94.7 | -86.92 | -83.22 | -80.69 | -78.65 | -76.41 | -70.84 | -68.23 | -63.39 | -58.76 | -66.79 | -72.23 | -80.09 | -81.44 | -40.28 | -33.35 |
Earnings Per Share EPS Growth | -1.74 | -1.76 | -1.94 | -1.96 | -1.90 | -1.75 | -1.67 | -1.73 | -1.80 | -1.93 | -1.88 | -1.94 | -1.92 | -1.96 | 67.54 | 39.75 | 11.68 | -8.95 | -95.85 | -82.33 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 114.73 | 144.24 | 161.87 | 177.31 | 127.99 | 151.09 | 174.38 | 187.42 | 202.87 | 226.15 | 149.06 | 162.01 | 173.52 | 188.81 | 111.52 | 122.13 | 133.28 | 149.06 | 81.83 | 92.2 |
Total Debt Total Debt Growth | 16.99 | 17.38 | 17.75 | 18.11 | 18.44 | 18.77 | 19.08 | 19.03 | 19.32 | 19.56 | 20.19 | 20.42 | 20.64 | 20.86 | 21.07 | 0.68 | 0.83 | 0.98 | 1.12 | 1.26 |
Net Cash (Debt) Net Cash Growth | 97.74 | 126.86 | 144.11 | 159.2 | 109.55 | 132.33 | 155.29 | 168.38 | 183.55 | 206.59 | 128.87 | 141.6 | 152.88 | 167.95 | 90.45 | 121.45 | 132.45 | 148.09 | 80.71 | 90.94 |
Net Cash Growth | -10.78% | -4.13% | -7.20% | -5.45% | -40.32% | -35.95% | 20.51% | 18.92% | 20.06% | 23.01% | 42.48% | 16.59% | 15.43% | 13.41% | 12.07% | 33.55% | 34.04% | 751.42% | 364.03% | 180.24% |
Net Cash Per Share Net Cash Per Share Growth | 1.51 | 2.10 | 2.57 | 3.07 | 2.20 | 2.67 | 3.14 | 3.62 | 4.21 | 5.21 | 3.35 | 3.91 | 4.49 | 5.61 | 3.38 | 6.21 | 10.71 | 28.70 | 194.48 | 228.01 |
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -91.28 | -84.74 | -88.23 | -83.35 | -78.71 | -79.81 | -73.24 | -73.37 | -71.89 | -63.85 | -64.47 | -59.83 | -55.81 | -54.6 | -48.67 | -46.6 | -42.47 | -32.41 | -24.08 | -22 |
Capital Expenditures CapEx Growth | -0.36 | -0.45 | -0.57 | -0.87 | -1.35 | -1.25 | -1.27 | -1.02 | -0.69 | -0.71 | -0.75 | -0.72 | -0.6 | -1.09 | -1.56 | -2.07 | -2.65 | -2.13 | -1.44 | -0.97 |
Free Cash Flow Free Cash Flow Growth | -91.64 | -85.19 | -88.8 | -84.22 | -80.06 | -81.06 | -74.51 | -74.39 | -72.58 | -64.56 | -65.22 | -60.55 | -56.42 | -55.7 | -50.23 | -48.67 | -45.13 | -34.54 | -25.52 | -22.97 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
PE Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.27 | 0.36 | 1.88 | - | - | - |